Immune Cell Therapy and Genome Engineering
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (20 April 2026) | Viewed by 1254
Special Issue Editor
Interests: mitochondria; cancer; chronic diseases; infectious disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Immune cell therapies, such as CAR-T cells, TCR-T cells, and NK cell therapies, are transforming the landscape of cancer treatment and chronic immune disorders. These therapies harness and reprogram the patient’s immune cells to recognize, target, and eliminate disease-causing cells. Beyond oncology, immune cell therapies are showing promise in infectious diseases and autoimmune conditions, offering a highly personalized therapeutic approach.
Regenerative therapy seeks to repair or replace damaged cells, tissues, and organs using stem cells, biomaterials, and bioengineered constructs. Innovations in mesenchymal stem cell (MSC) therapy, platelet-rich plasma (PRP), exosome therapies, and tissue engineering are redefining possibilities for healing and recovery in degenerative, inflammatory, and trauma-related conditions. These strategies hold significant promise for neurodegeneration, cardiovascular repair, musculoskeletal restoration, and beyond.
Advancements in gene editing technologies, such as CRISPR-Cas9, base editors, and prime editors, allow precise alterations in the genome to correct genetic defects or modulate disease pathways. These tools are rapidly being integrated into therapeutic pipelines for monogenic diseases, oncology, infectious diseases, and even for enhancing immune cell therapies. The combination of gene editing with cell-based platforms offers a powerful modality for curative interventions.
Understanding gene regulation at the epigenetic level—through DNA methylation, histone modifications, non-coding RNAs, and chromatin architecture—adds a crucial layer to precision medicine. Epigenetic modulation can influence disease susceptibility, therapeutic response, and aging processes. The emergence of epigenome-editing tools allows targeted modulation of gene expression without altering the underlying DNA sequence, offering reversible and programmable control of cellular behavior.
This Special Issue aims to highlight the integration of cutting-edge innovations in immune modulation, regeneration, genome engineering, and epigenetic reprogramming—ushering in a new era of systems-level, personalized, and regenerative medicine. These interwoven disciplines not only enhance therapeutic precision but also redefine the boundaries of what is biologically and clinically possible.
Prof. Dr. Kieu C. D. Nguyễn
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immune cell therapies
- regenerative therapy
- gene editing technologies
- epigenetic modulation
- precision medicine
- personalized therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
